Guangzhou LBP Medicine Science & Technology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 18.18%

Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has an Asset Resilience Ratio of 18.18% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Guangzhou LBP Medicine Science & Technol debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥238.51 Million
≈ $34.90 Million USD Cash + Short-term Investments

Total Assets

CN¥1.31 Billion
≈ $191.99 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how Guangzhou LBP Medicine Science & Technology Co Ltd's Asset Resilience Ratio has changed over time. See 688393 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou LBP Medicine Science & Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guangzhou LBP Medicine Science & Technol market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥238.51 Million 18.18%
Total Liquid Assets CN¥238.51 Million 18.18%

Asset Resilience Insights

  • Good Liquidity Position: Guangzhou LBP Medicine Science & Technology Co Ltd maintains a healthy 18.18% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Guangzhou LBP Medicine Science & Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangzhou LBP Medicine Science & Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
SKAN Group AG
SW:SKAN
Medical Instruments & Supplies 13.88%
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151
Medical Instruments & Supplies 26.12%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
Spineway
PA:ALSPW
Medical Instruments & Supplies -0.24%
I.Ceram SA
PA:ALICR
Medical Instruments & Supplies -1.61%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%

Annual Asset Resilience Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)

The table below shows the annual Asset Resilience Ratio data for Guangzhou LBP Medicine Science & Technology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 4.06% CN¥55.33 Million
≈ $8.10 Million
CN¥1.36 Billion
≈ $199.41 Million
+0.31pp
2023-12-31 3.75% CN¥52.56 Million
≈ $7.69 Million
CN¥1.40 Billion
≈ $204.85 Million
-8.85pp
2022-12-31 12.60% CN¥175.54 Million
≈ $25.69 Million
CN¥1.39 Billion
≈ $203.81 Million
-18.11pp
2021-12-31 30.71% CN¥419.42 Million
≈ $61.37 Million
CN¥1.37 Billion
≈ $199.84 Million
+14.42pp
2020-12-31 16.29% CN¥210.46 Million
≈ $30.80 Million
CN¥1.29 Billion
≈ $189.10 Million
+0.51pp
2019-12-31 15.78% CN¥84.88 Million
≈ $12.42 Million
CN¥537.96 Million
≈ $78.72 Million
+15.63pp
2013-12-31 0.15% CN¥376.60K
≈ $55.11K
CN¥257.13 Million
≈ $37.63 Million
-4.16pp
2012-12-31 4.31% CN¥8.27 Million
≈ $1.21 Million
CN¥191.92 Million
≈ $28.08 Million
+3.87pp
2011-12-31 0.43% CN¥484.40K
≈ $70.88K
CN¥111.40 Million
≈ $16.30 Million
--
pp = percentage points

About Guangzhou LBP Medicine Science & Technology Co Ltd

SHG:688393 China Medical Instruments & Supplies
Market Cap
$336.82 Million
CN¥2.30 Billion CNY
Market Cap Rank
#14501 Global
#4533 in China
Share Price
CN¥24.60
Change (1 day)
+1.03%
52-Week Range
CN¥21.74 - CN¥34.80
All Time High
CN¥58.43
About

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase… Read more